Author

Lila Glotfelty

DUPILUMAB IS EFFECTIVE IN TREATING EOE REGARDLESS OF BASELINE WEIGHT OR BMI: POOLED RESULTS FROM PART A AND PART B OF THE LIBERTY EOE TREET STUDY
DUPILUMAB IS EFFECTIVE IN TREATING EOE REGARDLESS OF BASELINE WEIGHT OR BMI: POOLED RESULTS FROM PART A AND PART B OF THE LIBERTY EOE TREET STUDY

Lila Glotfelty  et al.

EFFICACY OF DUPILUMAB IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AND PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY EOE TREET STUDY
EFFICACY OF DUPILUMAB IN PATIENTS WITH EOSINOPHILIC ESOPHAGITIS AND PRIOR USE OR PRIOR INADEQUATE RESPONSE, INTOLERANCE, OR CONTRAINDICATION TO SWALLOWED TOPICAL CORTICOSTEROIDS: RESULTS FROM PART C OF THE LIBERTY EOE TREET STUDY

Lila Glotfelty  et al.

DUPILUMAB IMPROVES HISTOLOGICAL AND ENDOSCOPIC FEATURES OF EOSINOPHILIC OESOPHAGITIS IN CHILDREN AGED 1–11 YEARS IN THE PHASE 3 EOE KIDS TRIAL
DUPILUMAB IMPROVES HISTOLOGICAL AND ENDOSCOPIC FEATURES OF EOSINOPHILIC OESOPHAGITIS IN CHILDREN AGED 1–11 YEARS IN THE PHASE 3 EOE KIDS TRIAL

Lila Glotfelty  et al.

DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY
DUPILUMAB EFFICACY AND SAFETY UP TO 52 WEEKS IN ADULT AND ADOLESCENT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM PARTS B AND C OF THE RANDOMIZED, PLACEBO-CONTROLLED, THREE-PART, PHASE 3 LIBERTY EOE TREET STUDY

Lila Glotfelty  et al.

Item 1 - 4 / 4
1